MétaCan
Menu
Back to cohort
Record W2309134523 · doi:10.1093/ofid/ofu052.283

417Comparison of ESBL rates and susceptibility of E. coli from IAI in the USA, Canada, and Mexico 2009-2013

2014· article· en· W2309134523 on OpenAlexaboutno aff
Robert E. Badal, Sibylle Lob, Meredith Hackel, Samuel K. Bouchillon, Aaron Johnson, Daryl J. Hoban, Dan Sahm

Bibliographic record

VenueOpen Forum Infectious Diseases · 2014
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBacterial Identification and Susceptibility Testing
Canadian institutionsnot available
Fundersnot available
KeywordsMedicinePathogenic organismCefepimeGerontologyDemographyMicrobiologyImipenemAntibioticsAntibiotic resistanceBiology

Abstract

fetched live from OpenAlex

Background. Extended-spectrum β-lactamase (ESBL) producing E. coli are multi-drug resistant and pose therapeutic challenges worldwide. This report from the Study for Monitoring Antimicrobial Resistance Trends (SMART) compares ESBL rates and susceptibility of E. coli from IAI from the USA, Canada, and Mexico in 2009-2013. Methods. 44 laboratories (28 USA, 12 Canada, 4 Mexico) each collected up to 100 consecutive gram-negative organisms from IAI each year; 5,183 of 12,421 (42%) were E. coli. Susceptibility was determined using CLSI broth microdilution methods and breakpoints. Trends in ESBL rates were assessed with the Cochran-Armitage test. Results. From 2009-2013, the proportion of ESBL+ E. coli showed significant increasing trends in all three countries. Susceptibility of selected drugs in 2013 (values ≥90% are shaded) and ESBL rates from 2009-2013 are shown in the table. Sensitivity analysis for the USA using only the 13 sites that submitted isolates in all 5 years confirmed the increasing ESBL rates (6, 6, 10, 6, and 14% in the years 2009-2013); however, a similar analysis for Canada did not find a significant trend (in 5 of 12 sites) in part due to a larger drop in 2013 than in the full analysis (9, 8, 11, 19, 10%). All 4 Mexican sites participated in all 5 years. In 2013, only AMK, ETP and IPM showed %S >90% in all 3 countries against E. coli. The much higher ESBL rate in Mexico corresponded to dramatically lower susceptibility rates than North America to most other drugs. Despite having significantly lower ESBL+ E. coli rates than Mexico, the US and Canada must take steps to contain further spread of these organisms, and Mexico itself must continue efforts (such as restricting fluoroquinolone use) to address this situation in which ESBL+ is the predominant phenotype among E. coli. Conclusion. E. coli ESBL rates were much higher in Mexico, and although all 3 countries showed increasing trends in the full analysis, they appear to be leveling off in Canada and Mexico. Disclosures. R. Badal, Merck: Independent Contractor, Consulting fee S. Lob, Merck: Independent Contractor, Consulting fee M. Hackel, Merck: Independent Contractor, Consulting fee S. Bouchillon, Merck: Independent Contractor, Consulting fee A. Johnson, Merck: Independent Contractor, Consulting fee D. Hoban, Merck: Independent Contractor, Consulting fee D. Sahm, Merck: Independent Contractor, Consulting fee

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.047
Threshold uncertainty score0.109

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0030.005
Science and technology studies0.0010.000
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.012
GPT teacher head0.264
Teacher spread0.253 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2014
Admission routes1
Has abstractyes

Explore more

Same venueOpen Forum Infectious DiseasesSame topicBacterial Identification and Susceptibility TestingFrench-language works237,207